PDD Holdings Inc., a multinational commerce group that owns and operates a portfolio of businesses.
FAIL · Does not pass the screen
79.75 USD
At the last full screen 2026-09-08
Screened 2026-09-08 · the tape above runs as of 23:00 UTC · 15 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
PDD Holdings holds its Markdown at $79.75. Consolidating, no directional conviction, held for 250 days.
As held on the ledger · 2026-09-08
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 250 days
Price at the screen
$79.75
Valuation
8.60 trailing · 6.42 forward price to earnings
Values screen
FAIL· score 10.0
Beta
-0.01
The Workings
Five Screens, Shown in Full
Does not pass. Revenue purity 5.9%
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
0.85%
Below 33%
Interest-bearing debt is just 0.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
17.28%
Below 33%
Cash held in interest-bearing accounts and securities is 17.3% of assets, under the one-third limit.
Pass
Receivables
0.81%
Below 49%
Money owed to the company is 0.8% of assets, under the 49% limit.
Pass
Revenue purity
5.92%
Below 5%
5.9% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads AVOID: it trades at roughly a 80% discount to our $143.63 fair value, 8.10% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 80.1% margin of safety to the base estimate.
Third-party analyst targets: 34 covering, consensus Buy. The average target sits +44% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Pinduoduo's Ethical Flaws Outweigh Market Value
Imagine every time you log onto Pinduoduo or Temu, you're contributing to a platform that's ethically lacking. That's the case with PDD Holdings, which despite its flashy interface and user engagement, fails our ethical screen - a critical factor for us at Titan Protect. This multinational commerce group's operations include the popular Pinduoduo platform, offering a wide array of products and shopping experiences, alongside Temu, an online marketplace for merchants.
Why it stands out, or rather, why we pass - the numbers are compelling on the surface. PDD Holdings boasts a forward P/E of 7.3x, which looks like a steal compared to the market, a revenue growth of 11%, and a profit margin of 22%. ROE is a respectable 25%, and the market consensus is a resounding buy with a median target of $116. Yet, the ethical failings cast a shadow over these figures, as revenue purity is a mere 5.9%, indicating a significant portion of the business may not align with our ethical standards.
Risk here is twofold: first, the ethical misalignment that leads us to avoid this opportunity, and second, the cyclical nature of the business which, while showing growth, could be a peak earnings trap with the low P/E. The market is currently valuing PDD Holdings at $89.52, well below our fair value of $144.91, indicating a substantial margin of safety. However, when ethics are non-negotiable, even a seemingly good deal must be passed over. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Ireland and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PDD trades on NASDAQ (the company is based in Ireland). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-25Accumulation$89.52+0.0%Entry 12
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (34 analysts) rates it buy, with a mean price target of $117. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-24Accumulation$89.52+0.0%Entry 11
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-23Accumulation$89.52+0.0%Entry 10
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-22Accumulation$89.52+0.0%Entry 9
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-21Accumulation$89.52-1.6%Entry 8
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-19Markdown$90.94+0.0%Entry 6
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-18Markdown · changed$90.94+0.0%Entry 5
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-08Distribution$90.94+6.9%Entry 4
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 6.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143.
2026-07-18Distribution$85.07+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 20%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (33 analysts) rates it buy, with a mean price target of $143.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
